Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO)

PLoS Medicine

Volumn 14, Issue 12, 2017, Pages

  Khan, Khalid S ^a   Moore, Philip A S ^b   Wilson, Matthew J ^c   Hooper, Richard ^d   Allard, Shubha ^e   Wrench, Ian ^f   Beresford, Lee ^d   Roberts, Tracy E ^g   McLoughlin, Carol ^g   Geoghegan, James ^b   Daniels, Jane P ^h   Catling, Sue ⁱ   Clark, Vicki A ^j   Ayuk, Paul ^k   Robson, Stephen ^l   Gao Smith, Fang ^g   Hogg, Matthew ^m   Lanz, Doris ^a   Dodds, Julie ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e NHS BLOOD AND TRANSPLANT   (United Kingdom)

^f SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^h UNIVERSITY OF NOTTINGHAM   (United Kingdom)

ⁱ SINGLETON HOSPITAL   (United Kingdom)

^j UNIVERSITY OF EDINBURGH   (United Kingdom)

^k ROYAL VICTORIA INFIRMARY   (United Kingdom)

^l NEWCASTLE UNIVERSITY   (United Kingdom)

^m ROYAL LONDON HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; CELL SALVAGE; CESAREAN SECTION; CLINICAL DECISION MAKING; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FATIGUE; FEMALE; FETOMATERNAL TRANSFUSION; HEALTH CARE PERSONNEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NUMBERS NEEDED TO TREAT; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PLACENTA PREVIA; PREECLAMPSIA; RANDOMIZED CONTROLLED TRIAL; STUDY DESIGN; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD SALVAGE; OPERATIVE BLOOD LOSS; PATIENT CARE PLANNING; PREGNANCY; PROCEDURES; PROGNOSIS; TREATMENT OUTCOME;

ADULT; BLOOD DONORS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; CESAREAN SECTION; FEMALE; HUMANS; OPERATIVE BLOOD SALVAGE; PATIENT CARE PLANNING; PREGNANCY; PROGNOSIS; TREATMENT OUTCOME;

EID: 85039561830     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1002471     Document Type: Article

References (34)

1. Betran AP, Torloni MR, Zhang JJ, Gülmezoglu AM, WHO Working Group on Caesarean SectionWHO statement on caesarean section rates. BJOG. 2016;123(5):667–70. doi: 10.1111/1471-0528.13526 26681211
2. Centre for Maternal and Child EnquiriesSaving mothers lives: reviewing maternal deaths to make motherhood safer: 2006–2008. BJOG. 2011;118(Suppl 1):1–203.
3. Bodelon C, Bernabe-Ortiz A, Schiff MA, Reed SD, Factors associated with peripartum hysterectomy. Obstet Gynecol. 2009;114(1):115–23. doi: 10.1097/AOG.0b013e3181a81cdd 19546767
4. Intensive Care National Audit & Research CentreFemale admissions (aged 16–50 years) to adult, general critical care units in England, Wales and Northern Ireland reported as ‘currently pregnant’ or ‘recently pregnant’. London: Obstetric Anaesthetists’ Association; 2013.
5. Bateman BT, Berman MF, Riley LE, Leffert LR, The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg. 2010;110(5):1368–73. doi: 10.1213/ANE.0b013e3181d74898 20237047
6. NHS Blood and TransplantSaving and improving lives: strategic plan 2015–20. London: NHS Blood and Transplant; 2015.
7. Catling S, Intraoperative cell salvage in obstetrics. Clin Risk. 2008;14(1):14–7.
8. Shander A, Isbister J, Gombotz H, Patient blood management: the global view. Transfusion. 2016;56(Suppl 1):S94–102.
9. Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, et al. Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. Transfusion. 2015;55(12):2807–15. doi: 10.1111/trf.13260 26264557
10. Woman Trial CollaboratorsEffect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105–16. doi: 10.1016/S0140-6736(17)30638-4 28456509
11. Jardine JE, Law P, Hogg M, Murphy D, Khan KS, C-SAFETYHaemorrhage at caesarean section: a framework for prevention and research. Curr Opin Obstet Gynecol. 2016;28(6):492–8. doi: 10.1097/GCO.0000000000000328 27787286
12. Davies L, Brown TJ, Haynes S, Payne K, Elliott RA, McCollum C, Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess. 2006;10(44):1–210.
13. Carless PA, Henry DA, Moxey AJ, O’Connell D, Brown T, Fergusson DA, Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2010;2010(3):CD001888.
14. White J, Qureshi H, Massey E, Needs M, Byrne G, Daniels G, et al. Guideline for blood grouping and red cell antibody testing in pregnancy. Transfus Med. 2016;26(4):246–63. doi: 10.1111/tme.12299 27074872
15. Qureshi H, Massey E, Kirwan D, Davies T, Robson S, White J, et al. British Committee for Standards in Haematology guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med. 2014;24(1):8–20. 25121158
16. Dhariwal SK, Khan KS, Allard S, Wilson M, Moore P, SALVO study groupDoes current evidence support the use of intraoperative cell salvage in reducing the need for blood transfusion in caesarean section?Curr Opin Obstet Gynecol. 2014;26(6):425–30. doi: 10.1097/GCO.0000000000000116 25259949
17. Geoghegan J, Middleton L, Moore P, Subseson G, Khan K, Daniels J, Routine cell salvage during elective caesarean section: a pilot randomised trial. Int J Obstet Anesth. 2015;24(1):86–7. doi: 10.1016/j.ijoa.2014.08.003 25499013
18. Geoghegan J, Daniels JP, Moore PA, Thompson PJ, Khan KS, Gülmezoglu AM, Cell salvage at caesarean section: the need for an evidence-based approach. BJOG. 2009;116(6):743–7. doi: 10.1111/j.1471-0528.2009.02129.x 19432562
19. Rainaldi MP, Tazzari PL, Scagliarini G, Borghi B, Conte R, Blood salvage during caesarean section. Br J Anaesth. 1998;80(2):195–8. 9602584
20. Rebarber A, Lonser R, Jackson S, Copel JA, Sipes S, The safety of intraoperative autologous blood collection and autotransfusion during cesarean section. Am J Obstet Gynecol. 1998;179(3 Pt 1):715–20. 9757977
21. Royal College of Obstetricians and Gynaecologists, Royal College of Anaesthetists. Classification of urgency of caesarean section—a continuum of risk. Good Practice No. 11. London: Royal College of Obstetricians and Gynaecologists; 2010.
22. Lucas DN, Yentis SM, Kinsella SM, Holdcroft A, May AE, Wee M, et al. Urgency of caesarean section: a new classification. J R Soc Med. 2000;93(7):346–50. doi: 10.1177/014107680009300703 10928020
23. Royal College of Obstetricians and Gynaecologists. Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management. Green-top Guideline No. 27. London: Royal College of Obstetricians and Gynaecologists; 2011.
24. Haynes SL, Bennett JR, Torella F, McCollum CN, Does washing swabs increase the efficiency of red cell recovery by cell salvage in aortic surgery?Vox Sang. 2005;88(4):244–8. doi: 10.1111/j.1423-0410.2005.00631.x 15877645
25. Working Party of the British Committee for Standards in Haematology Transfusion TaskforceGuidelines for the estimation of fetomaternal haemorrhage. London: British Society for Haematology; 2009.
26. Smets EM, Garssen B, Bonke B, De Haes JC, The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–25. 7636775
27. White IR, Horton NJ, Carpenter J, Pocock SJ, Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ. 2011;342:d40. doi: 10.1136/bmj.d40 21300711
28. Kahan BC, Jairath V, Doré CJ, Morris TP, The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies. Trials. 2014;15(1):139.
29. National Institute for Health and Care ExcellenceGuide to the methods of technology appraisal 2013. London: National Institute for Health and Care Excellence; 2013.
30. Briggs AH, Gray AM, Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess. 1999;3(2):1–134. 10448202
31. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR, A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–9. 8970487
32. Wood J, Freemantle N, King M, Nazareth I, Trap of trends to statistical significance: likelihood of near significant P value becoming more significant with extra data. BMJ. 2014;348:g2215. doi: 10.1136/bmj.g2215 24687314
33. Serious Hazards of Transfusion. Annual SHOT report 2015. Manchester: Serious Hazards of Transfusion; 2016.
34. de Haas M, Thurik FF, Koelewijn JM, van der Schoot CE, Haemolytic disease of the fetus and newborn. Vox Sang. 2015;109(2):99–113. doi: 10.1111/vox.12265 25899660